Transactions
13
Insider / Organon & Co.
Arjona Ferreira Juan Camilo
Head of R&D & CMO at Organon & Co.
- Company
- Organon & Co.
- Ticker
- OGN
- First filing on record
- November 10, 2025
- Latest trade on record
- August 11, 2026
- SEC filings
- EDGAR ↗
Arjona Ferreira Juan Camilo, Head of R&D & CMO at Organon & Co., has disclosed 13 transactions in OGN since November 10, 2025: 0 purchases (0 open-market buys) and 4 sales, worth about $118K at the reported prices. The latest was filed August 12, 2026, 1 day after the trade.
Open-market buys
0
Sales
4
Avg. disclosure lag
2.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Arjona Ferreira Juan Camilo made no purchases and 4 sales worth $118K, plus 9 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Arjona Ferreira Juan Camilo has traded 1 stock on record; the largest by dollars is OGN.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 4 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 8 | 80,522 | — |
| F | Shares withheld for tax | 4 | 14,442 | $118K |
| A | Grant or award | 1 | 200,333 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 10 | 0 | 3 · $102K |
| 2025 | 3 | 0 | 1 · $15K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| OGN | Option / conversion M | August 11, 2026 | August 12, 2026 | 1d | 11,519 | — | — | derivative | Form 4 ↗ | |
| OGN | Sell F | August 11, 2026 | August 12, 2026 | 1d | 4,134 | $14 | $56K | Form 4 ↗ | ||
| OGN | Option / conversion M | August 11, 2026 | August 12, 2026 | 1d | 11,519 | — | — | Form 4 ↗ | ||
| OGN | Option / conversion M | March 31, 2026 | April 2, 2026 | 2d | 13,431 | — | — | derivative | Form 4 ↗ | |
| OGN | Other A | March 31, 2026 | April 2, 2026 | 2d | 200,333 | — | — | derivative | Form 4 ↗ | |
| OGN | Sell F | March 31, 2026 | April 2, 2026 | 2d | 4,820 | $6 | $27K | Form 4 ↗ | ||
| OGN | Option / conversion M | March 31, 2026 | April 2, 2026 | 2d | 13,431 | — | — | Form 4 ↗ | ||
| OGN | Option / conversion M | March 29, 2026 | March 31, 2026 | 2d | 8,865 | — | — | derivative | Form 4 ↗ | |
| OGN | Sell F | March 29, 2026 | March 31, 2026 | 2d | 3,181 | $6 | $19K | Form 4 ↗ | ||
| OGN | Option / conversion M | March 29, 2026 | March 31, 2026 | 2d | 8,865 | — | — | Form 4 ↗ | ||
| OGN | Option / conversion M | November 7, 2025 | November 10, 2025 | 3d | 6,446 | — | — | derivative | Form 4 ↗ | |
| OGN | Sell F | November 7, 2025 | November 10, 2025 | 3d | 2,307 | $7 | $15K | Form 4 ↗ | ||
| OGN | Option / conversion M | November 7, 2025 | November 10, 2025 | 3d | 6,446 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 12, 2026 | Form 4 | 0001628280-26-056061 | 3 | published | EDGAR ↗ |
| April 2, 2026 | Form 4 | 0001628280-26-023188 | 4 | published | EDGAR ↗ |
| March 31, 2026 | Form 4 | 0001628280-26-022387 | 3 | published | EDGAR ↗ |
| November 10, 2025 | Form 4 | 0001628280-25-051052 | 3 | published | EDGAR ↗ |
Other insiders at Organon & Co.
- Holzbaur Lynette SVP and Corporate Controller 18 rows
- Drinane Juliana Papa Interim Head of Mfg & Supply 15 rows
- Morrissey Joseph T. Jr. Interim CEO 15 rows
- WALSH MATTHEW M Chief Financial Officer 15 rows
- COX CARRIE SMITH Director 14 rows
- Falcione Aaron Chief Human Resources Officer 14 rows
- Nisita Vittorio Head of Global Business Svcs 14 rows
- Stahler Rachel A Chief Information Officer 14 rows
- Weaver Kirke Gen. Counsel & Corp. Secy. 14 rows
- Karp Daniel Executive VP, Corp. Dev. 10 rows
Everyone on file, with contracts and lobbying under the company's name: Organon & Co..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 4 | 13 | November 10, 2025 | August 12, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.